Risk factor assessment for new onset diabetes: Literature review

George Bakris*, Jack Stockert, Mark E Molitch, Qian Zhou, Annette Champion, Peter Bacher, James Sowers

*Corresponding author for this work

Research output: Contribution to journalReview article

27 Scopus citations

Abstract

Metabolic syndrome (MS), typified by hypertension, abdominal obesity, dyslipidaemia and impaired glucose metabolism, is a precursor of type 2 diabetes. Thiazide diuretics (TD) and beta-blockers are associated with increased risk of diabetes in patients with hypertension; however, the role of these agents in development of diabetes in MS patients is unknown. We reviewed the literature regarding risk factors for diabetes development and compared this with data from the Study of Trandolapril/ Verapamil SR And Insulin Resistance (STAR), which investigated the effects of two fixed-dose combinations (FDCs) [trandolapril/verapamil SR and losartan/hydrochlorothiazide (L/H)] on glucose control and new diabetes in MS patients. In STAR, logistic regression modelling identified haemoglobin A1c [odds ratio (OR) 4.21 per 1% increment; p=0.003), L/H treatment (OR 4.04; p=0.002) and 2-h oral glucose tolerance test glucose levels (OR 1.39 per 10mg/dl increments; p<0.001) as baseline predictors of diabetes. These data support prior analyses and suggest that choice of antihypertensive agent is important. Patients with MS may be at lower risk of diabetes when using a FDC calcium channel blocker + angiotensin-converting enzyme inhibitor compared with an angiotensin receptor blocker + TD.

Original languageEnglish (US)
Pages (from-to)177-187
Number of pages11
JournalDiabetes, Obesity and Metabolism
Volume11
Issue number3
DOIs
StatePublished - Jan 1 2009

Keywords

  • Angiotensin receptor blocker
  • Calcium channel blocker
  • Metabolic syndrome
  • Thiazide diuretic
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Risk factor assessment for new onset diabetes: Literature review'. Together they form a unique fingerprint.

  • Cite this